Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
Motzer, Robert J, Dr, Escudier, Bernard, MD, Tomczak, Piotr, MD, Hutson, Thomas E, DO, Michaelson, M Dror, MD, Negrier, Sylvie, Prof, Oudard, Stephane, Prof, Gore, Martin E, Prof, Tarazi, Jamal, MD, Hariharan, Subramanian, MD, Chen, Connie, PharmD, Rosbrook, Brad, MS, Kim, Sinil, MD, Rini, Brian I, MD
Published in The lancet oncology (01.05.2013)
Published in The lancet oncology (01.05.2013)
Get full text
Journal Article
Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
Hutson, Thomas E, Prof, Lesovoy, Vladimir, Prof, Al-Shukri, Salman, Prof, Stus, Viktor P, Prof, Lipatov, Oleg N, Prof, Bair, Angel H, PhD, Rosbrook, Brad, MS, Chen, Connie, PharmD, Kim, Sinil, MD, Vogelzang, Nicholas J, Prof
Published in The lancet oncology (01.12.2013)
Published in The lancet oncology (01.12.2013)
Get full text
Journal Article
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
Rini, Brian I, Dr, Escudier, Bernard, MD, Tomczak, Piotr, MD, Kaprin, Andrey, Prof, Szczylik, Cezary, MD, Hutson, Thomas E, DO, Michaelson, M Dror, MD, Gorbunova, Vera A, Prof, Gore, Martin E, Prof, Rusakov, Igor G, Prof, Negrier, Sylvie, Prof, Ou, Yen-Chuan, Prof, Castellano, Daniel, MD, Lim, Ho Yeong, Prof, Uemura, Hirotsugu, Prof, Tarazi, Jamal, MD, Cella, David, PhD, Chen, Connie, PharmD, Rosbrook, Brad, MS, Kim, Sinil, MD, Motzer, Robert J, MD
Published in The Lancet (British edition) (03.12.2011)
Published in The Lancet (British edition) (03.12.2011)
Get full text
Journal Article
Phase II Study of Axitinib in Sorafenib-Refractory Metastatic Renal Cell Carcinoma
RINI, Brian I, WILDING, George, HUDES, Gary, STADLER, Walter M, KIM, Sinil, TARAZI, Jamal, ROSBROOK, Brad, TRASK, Peter C, WOOD, Laura, DUTCHER, Janice P
Published in Journal of clinical oncology (20.09.2009)
Published in Journal of clinical oncology (20.09.2009)
Get full text
Journal Article
Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid Tumors
RINI, Brian I, SCHILLER, Joan H, KIM, Sinil, RIXE, Olivier, FRUEHAUF, John P, COHEN, Ezra E. W, TARAZI, Jamal C, ROSBROOK, Brad, BAIR, Angel H, RICART, Alejandro D, OLSZANSKI, Anthony J, LETRENT, Kristen J
Published in Clinical cancer research (01.06.2011)
Published in Clinical cancer research (01.06.2011)
Get full text
Journal Article
Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone‐sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study
Iguchi, Taro, Kimura, Go, Fukasawa, Satoshi, Suzuki, Hiroyoshi, Uemura, Hiroji, Nishimura, Kazuo, Matsumoto, Hiroaki, Yokomizo, Akira, Armstrong, Andrew J, Rosbrook, Brad, Sugg, Jennifer, Baron, Benoit, Chen, Lucy, Kunieda, Futoshi, Stenzl, Arnulf
Published in International journal of urology (01.07.2021)
Published in International journal of urology (01.07.2021)
Get full text
Journal Article
A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design
Freedland, Stephen J, De Giorgi, Ugo, Gleave, Martin, Rosbrook, Brad, Shen, Qi, Sugg, Jennifer, Haas, Gabriel P, Shore, Neal D
Published in BMJ open (12.08.2021)
Published in BMJ open (12.08.2021)
Get full text
Journal Article
Randomized, Placebo-Controlled, Double-Blind, Phase II Study of Axitinib Plus Docetaxel Versus Docetaxel Plus Placebo in Patients With Metastatic Breast Cancer
RUGO, Hope S, STOPECK, Alison T, BAIR, Angel H, SOULIERES, Denis, JOY, Anil A, CHAN, Stephen, VERMA, Shailendra, LLUCH, Anna, LIAU, Katherine F, KIM, Sinil, BYCOTT, Paul, ROSBROOK, Brad
Published in Journal of clinical oncology (20.06.2011)
Published in Journal of clinical oncology (20.06.2011)
Get full text
Journal Article
Conference Proceeding
Axitinib Versus Sorafenib in First-Line Metastatic Renal Cell Carcinoma: Overall Survival From a Randomized Phase III Trial
Hutson, Thomas E, Al-Shukri, Salman, Stus, Viktor P, Lipatov, Oleg N, Shparyk, Yaroslav, Bair, Angel H, Rosbrook, Brad, Andrews, Glen I, Vogelzang, Nicholas J
Published in Clinical genitourinary cancer (01.02.2017)
Published in Clinical genitourinary cancer (01.02.2017)
Get full text
Journal Article
Long-term Duration of First-Line Axitinib Treatment in Advanced Renal Cell Carcinoma
Rini, Brian I., Gruenwald, Victor, Jonasch, Eric, Fishman, Mayer N., Tomita, Yoshihiko, Michaelson, M. Dror, Tarazi, Jamal, Cisar, Laura, Hariharan, Subramanian, Bair, Angel H., Rosbrook, Brad, Hutson, Thomas E.
Published in Targeted oncology (01.06.2017)
Published in Targeted oncology (01.06.2017)
Get full text
Journal Article
ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
Armstrong, Andrew J, Szmulewitz, Russell Z, Petrylak, Daniel P, Holzbeierlein, Jeffrey, Villers, Arnauld, Azad, Arun, Alcaraz, Antonio, Alekseev, Boris, Iguchi, Taro, Shore, Neal D, Rosbrook, Brad, Sugg, Jennifer, Baron, Benoit, Chen, Lucy, Stenzl, Arnulf
Published in Journal of clinical oncology (10.11.2019)
Published in Journal of clinical oncology (10.11.2019)
Get full text
Journal Article
Reply to R. Sun et al
Armstrong, Andrew J, Rosbrook, Brad, Yamada, Shunsuke
Published in Journal of clinical oncology (20.12.2022)
Published in Journal of clinical oncology (20.12.2022)
Get full text
Journal Article
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
Atkins, Michael B, Plimack, Elizabeth R, Puzanov, Igor, Fishman, Mayer N, McDermott, David F, Cho, Daniel C, Vaishampayan, Ulka, George, Saby, Olencki, Thomas E, Tarazi, Jamal C, Rosbrook, Brad, Fernandez, Kathrine C, Lechuga, Mariajose, Choueiri, Toni K
Published in The lancet oncology (01.03.2018)
Published in The lancet oncology (01.03.2018)
Get full text
Journal Article
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Armstrong, Andrew J, Azad, Arun A, Iguchi, Taro, Szmulewitz, Russell Z, Petrylak, Daniel P, Holzbeierlein, Jeffrey, Villers, Arnauld, Alcaraz, Antonio, Alekseev, Boris, Shore, Neal D, Gomez-Veiga, Francisco, Rosbrook, Brad, Zohren, Fabian, Yamada, Shunsuke, Haas, Gabriel P, Stenzl, Arnulf
Published in Journal of clinical oncology (20.05.2022)
Published in Journal of clinical oncology (20.05.2022)
Get full text
Journal Article
Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial
Armstrong, Andrew J., Lin, Ping, Tombal, Bertrand, Saad, Fred, Higano, Celestia S., Joshua, Anthony M., Parli, Teresa, Rosbrook, Brad, van Os, Steve, Beer, Tomasz M.
Published in European urology (01.09.2020)
Published in European urology (01.09.2020)
Get full text
Journal Article
Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses
Armstrong, Andrew J, Shore, Neal D, Szmulewitz, Russell Z, Petrylak, Daniel P, Holzbeierlein, Jeffrey, Villers, Arnauld, Azad, Arun, Alcaraz, Antonio, Alekseev, Boris, Iguchi, Taro, Gomez-Veiga, Francisco, Rosbrook, Brad, Lee, Ho-Jin, Haas, Gabriel P, Stenzl, Arnulf
Published in The Journal of urology (01.05.2021)
Published in The Journal of urology (01.05.2021)
Get full text
Journal Article
Sunitinib in patients with pancreatic neuroendocrine tumors: update of safety data
Valle, Juan W, Borbath, Ivan, Rosbrook, Brad, Fernandez, Kathrine, Raymond, Eric
Published in Future oncology (London, England) (01.04.2019)
Published in Future oncology (London, England) (01.04.2019)
Get full text
Journal Article
The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES
Armstrong, Andrew J., Iguchi, Taro, Azad, Arun A., Villers, Arnauld, Alekseev, Boris, Petrylak, Daniel P., Szmulewitz, Russell Z., Alcaraz, Antonio, Shore, Neal D., Holzbeierlein, Jeffrey, Gomez-Veiga, Francisco, Rosbrook, Brad, Zohren, Fabian, Haas, Gabriel P., Gourgiotti, Georgia, El-Chaar, Nader, Stenzl, Arnulf
Published in European urology (01.08.2023)
Published in European urology (01.08.2023)
Get full text
Journal Article
Radiographic progression in the absence of prostate-specific antigen (PSA) progression in patients with metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analysis of ARCHES
Armstrong, Andrew J., Mottet, Nicolas, Iguchi, Taro, Szmulewitz, Russell Zelig, Holzbeierlein, Jeffrey, Villers, Arnauld, Alcaraz, Antonio, Alekseev, Boris, Shore, Neal D., Gomez-Veiga, Francisco, Rosbrook, Brad, Zohren, Fabian, Lee, Ho-Jin, Haas, Gabriel P., Stenzl, Arnulf, Azad, Arun
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article